Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2014
03/26/2014CN103664893A Novel DPP-4 inhibitor, and preparation method and medicinal application thereof
03/26/2014CN103664892A Crystal of quinoline derivative
03/26/2014CN103664891A Soft soil foundation curing agent
03/26/2014CN103664890A Crystal of quinoline derivative and preparation method of crystal
03/26/2014CN103664889A Lansoprazole compound
03/26/2014CN103664888A Preparation method of esomeprazole trihydrate
03/26/2014CN103664887A Preparation method of esomeprazole
03/26/2014CN103664886A Preparation method of 2-[[[4-(3-methoxypropoxy)-3-methylpyridine-2-yl]-methyl]thio]-1H-benzimidazole
03/26/2014CN103664885A Preparation method of benzimidazole proton pump inhibitor intermediate
03/26/2014CN103664884A Tyrosine kinase inhibitor for nitrogen hetero-aromatic ring and derivatives thereof
03/26/2014CN103664883A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664882A Dabigatran etexilate in crystal modification form, and preparation method and use of dabigatran etexilate
03/26/2014CN103664881A Dabigatran etexilate of crystallized variant form B as well as preparation method thereof and application
03/26/2014CN103664880A Novel anticoagulation medicine and preparation method and application thereof
03/26/2014CN103664879A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664878A Hetero-aromatic ring and derivative type tyrosine kinase inhibitor thereof
03/26/2014CN103664877A Quinoline, preparation method and application of quinoline
03/26/2014CN103664876A Quinoline derivative and usage thereof
03/26/2014CN103664875A Novel method for synthesizing 1,4,5,6-tetrahydropyrimidine derivative
03/26/2014CN103664874A Preparation method of antineoplastic drug imatinib
03/26/2014CN103664873A 3-(3-aminopiperidin-1-yl)-5-oxo-1,2,4-triazine derivates as dipeptidyl peptidase iv(dpp-iv) inhibitors
03/26/2014CN103664872A Salt of pyrryl isoquinoline ketone derivative
03/26/2014CN103664871A Isoquinoline derivative salt
03/26/2014CN103664802A Quinazoline analogs as receptor tyrosine kinase inhibitors
03/26/2014CN103664801A Method of preparing Alogliptin
03/26/2014CN103664800A Compounds for treating narrow chamber angle and application thereof
03/26/2014CN103664798A Compounds for treating traumatic brain injury diseases and application thereof
03/26/2014CN103664787A Alkyne heteraromatic ring compound and application thereof
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN103664748A Pyrene compound and organic light emitting diode device including the same
03/26/2014CN103664734A Heterocyclic hydroxamic acid compound as well as pharmaceutical composition and application thereof
03/26/2014CN103664430A Method for preparing coupling product through visible light catalysis cross dehydrogenation coupling
03/26/2014CN102850325B Preparation method of Dabigatran etexilate key intermediate
03/26/2014CN102625797B Substituted heterocyclic compounds as kinases inhibitors and method of use thereof
03/26/2014CN102391191B Piperazine di-thiocarboxylic acid ester derivative of 2,4-di-aminoquinazoline, as well as preparation method and anti-tumor application of the derivative
03/26/2014CN102245577B 2-[(1-cyanopropyl)carbamoyl]-5-chloromethyl nicotinic acids and the use thereof in manufacturing herbicidal imidazolinones
03/26/2014CN102056905B Novel uracil compound having inhibitory activity on human deoxyuridine triphosphatase or salt thereof
03/26/2014CN102030737B Clinafloxacin amino derivatives and application thereof
03/26/2014CN101715442B Heterocyclic aspartyl protease inhibitors
03/26/2014CN101472910B 1- [(4- [benzoyl (methyl) amino] -3- (phenyl) butyl] azetidine derivatives for the treatment of gastrointestinal disorders
03/25/2014US8680284 Preparation process of the sodium salt of esomeprazole
03/25/2014US8680283 Process for the preparation of 5-substituted 1-alkyltetrazolyl oxime derivatives
03/25/2014US8680278 Enantioselective process for preparing a substituted alkanoic acid
03/25/2014US8680277 Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
03/25/2014US8680272 3-arylethynyl substituted quinazolinone compounds
03/25/2014US8680269 Pesticidal compositions
03/25/2014US8680122 Substituted pyrrolones as allosteric modulators of glucokinase
03/25/2014US8680120 Indole derivative or pharmaceutically acceptable salt thereof
03/25/2014US8680119 Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
03/25/2014US8680118 Therapeutic agents useful for treating pain
03/25/2014US8680115 Tetrahydroquinoline analogues as muscarinic agonists
03/25/2014US8680113 BMI-1 protein expression modulators
03/25/2014US8680104 Piperazinylpiperidine derivatives as chemokine receptor antagonists
03/25/2014US8680092 Nitrogenous heterocyclic compound and medicinal use thereof
03/25/2014US8680091 6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
03/25/2014US8680090 Sulfonyl containing benzothiazole inhibitors of endothelial lipase
03/25/2014US8680012 4-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,6-diones and cyclohexanetriones as novel herbicides
03/25/2014US8679773 Kits pertaining to analyte determination
03/25/2014CA2699989C N-phenyl-dioxo-hydro pyrimidines useful as hepatitis c virus (hcv) inhibitor
03/25/2014CA2623879C Sulfonamide derivatives and use thereof for the modulation of metalloproteinases
03/25/2014CA2617099C Macrocyclic inhibitors of hepatitis c virus
03/25/2014CA2610105C Process for the synthesis of organic compounds
03/25/2014CA2594418C N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
03/20/2014WO2014043608A2 Smoothened modulators and methods of use thereof
03/20/2014WO2014043252A2 Therapeutic hydroxypyridinones, hydroxypyrimidinones and hydroxypyridazinones
03/20/2014WO2014042238A1 Sulfonamide compound
03/20/2014WO2014041362A1 Uv radiation cleavable compounds
03/20/2014WO2014041007A1 Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson's disease
03/20/2014WO2014040969A1 2-oxo-2,3-dihydro-indoles for the treatment of cns disorders
03/20/2014WO2014040965A1 Inhibitors of bruton's tyrosine kinase
03/20/2014WO2014040555A1 Nitrogen-containing heteroaromatic ring derivative as tyrosine kinase inhibitor
03/20/2014WO2014040243A1 N-substituted phenyl-n'-substituted heterocyclic urea compound and application thereof as anticancer medicament
03/20/2014US20140081025 Heteroaromatic ring derivative
03/20/2014US20140081019 Process for the preparation of deuterated compounds containing n-alkyl groups
03/20/2014US20140080866 Tris-Quaternary Ammonium Salts and Methods for Modulating Neuronal Nicotinic Acetylcholine Receptors
03/20/2014US20140080860 Novel hybrid cholinesterase inhibitors
03/20/2014US20140080849 Small Molecular Inhibitors of RAD51 Recombinase and Methods Thereof
03/20/2014US20140080839 Oligomer-protein tyrosine kinase inhibitor conjugates
03/20/2014US20140080835 Quinazolinone derivatives as parp inhibitors
03/20/2014US20140080831 Compounds useful for treating cancer
03/20/2014US20140080829 Pyrimidyl cyclopentanes as akt protein kinase inhibitors
03/20/2014US20140080828 Imidazolyl amide compounds and uses related thereto
03/20/2014US20140080807 Substituted indazole derivatives active as kinase inhibitors
03/20/2014US20140080803 Novel trpv3 modulators
03/20/2014US20140080798 Vegfr3 inhibitors
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080780 identification of compounds that disperse tdp-43 inclusions
03/20/2014US20140080770 Arylalkylamine compound and process for preparing the same
03/20/2014US20140079784 Aerosolized lfa-1 antagonists for use in localized treatment of immune related disorders
03/20/2014US20140079693 Kinase inhibitors and methods of their use
03/20/2014US20140079667 Tetrazolones as inhibitors of fatty acid synthase
03/20/2014US20140079666 Pyrimidinone compounds and methods for preventing and treating influenza
03/20/2014US20140076036 Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
03/19/2014EP2708537A1 Heteroaromatic ring derivative
03/19/2014EP2708532A1 4-aminoquinazoline derivatives and uses thereof
03/19/2014EP2707364A1 Process for the manufacture of dabigatran etexilate and intermediates thereof
03/19/2014EP2707361A1 Fused heterocyclic compounds as sodium channel modulators
03/19/2014EP2707360A1 Dabigatran etexilate and related substances, processes and compositions, and use of the substances as reference standards and markers
03/19/2014EP2707359A1 Substituted indazole derivatives active as kinase inhibitors
03/19/2014EP2707102A2 Carbonic anhydrase targeting agents and methods of using same
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 1080